BREWIN DOLPHIN LTD - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$11,000
+12.8%
700.0%0.00%
Q3 2021$9,752
+6.2%
700.0%0.00%
Q2 2021$9,183
-14.0%
700.0%0.00%
-100.0%
Q1 2021$10,672
-41.4%
70
-61.7%
0.00%0.0%
Q4 2020$18,199
+4.3%
1830.0%0.00%0.0%
Q3 2020$17,444
-14.8%
1830.0%0.00%
-50.0%
Q2 2020$20,469
-21.4%
183
-48.9%
0.00%
-33.3%
Q1 2020$26,034
-30.3%
3580.0%0.00%0.0%
Q4 2019$37,336
+4.8%
3580.0%0.00%
-25.0%
Q3 2019$35,635
+70.6%
358
+95.6%
0.00%
+100.0%
Q2 2019$20,889
-9.2%
1830.0%0.00%
-33.3%
Q1 2019$23,005
-7.4%
1830.0%0.00%0.0%
Q4 2018$24,833
-50.6%
1830.0%0.00%
-50.0%
Q3 2018$50,232
+32.5%
1830.0%0.01%
+50.0%
Q2 2018$37,912
+24.8%
183
-0.5%
0.00%0.0%
Q1 2018$30,389
+20.6%
1840.0%0.00%
+33.3%
Q4 2017$25,195
+0.6%
1840.0%0.00%0.0%
Q3 2017$25,0521840.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders